Variant position: 497 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1230 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human NKFHVKFADHVVCEEECKYA MLALNCICPATSTLITLLVHT
Mouse NKFHVKFADHVVCEEECKYA MLALNCICPATSTLITLLVHT
Rat NKFHVKFADHVVCEEECKYA MLALNCICPATSTLITLLVHT
Chicken NKFHVKFADHVVCEEECKYA MLALNCVCPATSTLITLLVHT
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 1230 Potassium channel subfamily T member 1
326 – 1230 Cytoplasmic
475 – 596 RCK N-terminal
Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes.
Parrini E.; Marini C.; Mei D.; Galuppi A.; Cellini E.; Pucatti D.; Chiti L.; Rutigliano D.; Bianchini C.; Virdo S.; De Vita D.; Bigoni S.; Barba C.; Mari F.; Montomoli M.; Pisano T.; Rosati A.; Guerrini R.;
Hum. Mutat. 38:216-225(2017)
Cited for: VARIANTS DEE14 VAL-497 AND GLU-928;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.